CDX-011

CR011-vcMMAE · Celldex Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CDX-011, covering 2017-07-02 to 2017-07-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer [Phase 2]